Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without Hemolysis
Completed · Not applicable
Conditions studied: Sickle Cell Anemia
In brief
People who have Sickle Cell Anemia (HbSS) produce red blood cells with shorter lifespans. These red blood cells breakdown faster, and this is called hemolysis. When red blood cells breakdown, a tiny amount of Carbon Monoxide (CO) is released into the blood and is eliminated in exhaled breath. This research study will use a device called CoSense™, which will measure Carbon Monoxide (CO) levels in breath. The purpose of the study is to see how well the device measures the CO levels that an individual breathes out.
Key facts
- Study ID
- NCT01848691
- Run by
- Ashutosh Lal
- People needed
- 40
- Starts
- 2012-10-01
- Expected to finish
- 2014-03-01
- Last updated by the study team
- 2014-06-02
Who can join
Age: 5 and older, up to 14. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Parental / legal guardian consent
- Subject assent for participants ages 7 and above
- Male and female children ages 5 - 14 years old
- For Hb SS subjects, hemoglobin ≤ 10 g/dL (based on a laboratory tests performed over the last 6 months and confirmed within 4 weeks prior to breath collection, as part of the subject's clinical care)
You may not qualify if…
- For healthy subjects, known to have the sickle cell trait
- Had a red blood cell transfusion within 12 weeks prior to enrollment
- Currently a primary smoker or was a primary smoker within 4 weeks prior to enrollment
- Exposed to second hand smoke within 24 hours prior to breath sample collections
- Have an upper respiratory infection within 2 weeks of ETCO measurements
Where it is running
- Children's Hospital & Research Center Oakland — Oakland, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.